ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of March

March 29, 2013

Toxicity Of Salts Regimen Should Remain A Concern.

January 4, 2002

Competition For Center Grants Higher In FY95, Kimes Tells BSC

November 25, 1994

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

November 22, 2006

Stephen Gruber Named Director at USC Norris; TGen and Cedars-Sinai to Coordinate Phase I Trials.

October 21, 2011

NCAB Ok’s Funding First Three Years Of Diet Trial

December 7, 1990